Skip to content
Riskpilot
← Back to search
Sign in
Get full access
dermipath AB
AB
Active
Org 5569996241
Vaxmoravägen 25 B, 192 48
Sollentuna
Medical specialists activities
· NACE 8622
Est. 2015
1 employees
Watchlist
Share
Sweden
/
Companies
/
Medical specialists activities
/
dermipath AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
1M
2021
1M
2022
0M
2023
0M
2024
1M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2021
1M
2022
0M
2023
0M
2024
0M
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
628
1 473
379
338
639
Staff expenses
—
—
—
−377
−395
EBITDA
189
997
−198
−263
14
Depreciation & amort.
−8
−0
−0
—
—
EBIT
181
997
−198
−263
14
Net financials
—
—
2
−2
0
Profit before tax
131
747
4
−64
14
Tax
−31
−157
−7
—
—
Net profit
100
590
−3
−64
14
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
1 297
2 158
1 736
1 313
1 325
Equity
164
640
442
277
291
Long-term debt
0
0
0
—
—
Short-term debt
147
283
259
200
199
Total debt
147
283
259
200
199
Financial ratios
5-year trend
EBITDA margin
2.2%
This company
15.8%
Market median
-86% vs market
2021
2025
Equity ratio
22.0%
This company
38.2%
Market median
-42% vs market
2021
2025
Return on equity
4.9%
This company
18.4%
Market median
-73% vs market
2021
2025
Net profit margin
2.2%
This company
8.1%
Market median
-73% vs market
2021
2025
Asset turnover
0.48×
This company
1.12×
Market median
-57% vs market
2021
2025
Debt / equity
3.55×
This company
0.62×
Market median
-473% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
More on dermipath AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network